Trial Profile
A Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2009
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Pfizer
- 12 Feb 2009 New trial record